Skip to main content
Clinical Trials/CTRI/2018/02/012238
CTRI/2018/02/012238Other未知

Cost effective non invasive diagnostic modalities and predictive model for development and progression of fibrosis among patients with Hepatitis B, Hepatitis C infection or non alcoholic fatty liver disease: A hospital based retrospective followed by prospective cohort study

Institute of liver and Biliary Sciences0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Other

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Age 18 years and above Patients who underwent liver biopsy with underlying etiology as HBV, HCV, NASH or cryptogenic or ALD (inpatient or outpatient) Metavir Fibrosis Score F0-3 for prospective study design

Exclusion Criteria

  • Not willing to participate in the study Patients with chronic liver disease of other

Investigators

Similar Trials